| Financial Year |
March 31 2023 |
| Monetary Funds |
701,740,060.80 |
| Held-for-trading Financial Assets |
80,868,340.72 |
| Notes Receivable |
-- |
| Accounts Receivable |
301,473,142.67 |
| Advances to Suppliers |
21,897,367.91 |
| Other Receivables |
12,572,809.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,898,377.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
54,822,584.13 |
| Total Current Assets |
1,409,666,451.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,712,729.90 |
| Investment Properties |
-- |
| Fixed Assetes |
971,000,630.60 |
| Under-construction Projects |
633,367,815.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,628,961.77 |
| R&D expenses |
-- |
| Goodwill |
110,278,073.17 |
| Long-Term Deferred and Prepaid Expenses |
5,479,355.25 |
| Deferred Income Tax Assets |
31,987,572.64 |
| Other Non-Current Assets |
74,398,582.47 |
| Sub-Total of Non-Current Assets |
2,326,066,131.38 |
| Total Assets |
3,735,732,583.30 |
| Short-Term Loans |
366,095,125.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
186,840,261.90 |
| Accounts Received In Advance |
435,593.70 |
| Employee Compensation Payable |
11,579,338.37 |
| Taxes Payable |
20,700,849.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,304,898.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,769,140.35 |
| Other Current Liabilities |
513,379.33 |
| Sub-Total of Current Liabilities |
606,997,615.05 |
| Long-term Loans |
46,000,000.00 |
| Bonds Payable |
498,526,031.61 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,337,431.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
669,021,658.09 |
| Total Liabilities |
1,276,019,273.14 |
| Paid-In Capital(Or Share Stock) |
585,181,199.00 |
| Capital Surplus |
784,495,352.01 |
| Surplus Reserve |
26,831,091.51 |
| LESS:Treasury Stock |
29,994,660.00 |
| Undistributed Profits |
501,238,839.00 |
| Minority Stockholder's Interest |
468,421,095.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,991,292,215.05 |
| Owner's Equity（Stockholder's Equity） |
2,459,713,310.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,735,732,583.30 |
